Indian pharmaceutical company Cipla has recalled six batches of its Albuterol Sulfate HFA Inhalation Aerosol in the US due to a container d...

The acquisition of these two brands will expand the company's inhalation product portfolio in the US and strengthen its presence in the res...

The approved product is a generic version of ProAir HFA of Teva Branded Pharmaceutical Products R&D, Inc. In a regulatory filing, Lupin sai...

A second stimulus package India is poised to announce in coming days will be worth around Rs 1 lakh crore.

As many as 19 stocks turned ‘overbought’ as they crossed the 70 mark on RSI indicator.

Following the development, the scrip hit its 15 per cent upper circuit limit at Rs 589.95.

In a regulatory filing the company said "it has received final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfa...

Not only prevalent in developed countries, but it is also a major problem in the developing countries.

Merck & Co Inc's new two-in-one respiratory drug Dulera has been approved by the US Food and Drug Administration, the US company said on Th...

The bidding process for the generics business of German pharmaceutical corporation Merck is set to begin in a few days. The advisors to Mer...